We use essential cookies to make this site work.
We also use analytics cookies, by accepting you agree to their use.
You have accepted analytics cookies. You can change this choice at any time in settings.
You have rejected analytics cookies. You can change this choice at any time in settings.
STAY INFORMED! - If you are interested in receiving newsletters and updates, please send us your email to cksdrg@health.gov.sk
A List of requests and responses via feedback - CKS DRG
Thank You for your feedback. Your requests are being processed systematically according to the received date.
Current number of requests: 1027
Number of requests till 31.03.2026: 1006
Number of requests after 31.03.2026: 21
Handled suggestions: 690
Open suggestions: 35
Pending suggestions: 253
Suggestions downloaded by the submitter: 49
Všeobecná nemocnica Žiar nad Hronom
Created at: 28.03.2025
Processed at: 07.04.2026
Attributable item
Incentive to create
Requirement for PP medicine - tenecteplase
The opinion is set out in feedback number 659 - https://www.cksdrg.sk/sk/spatna-vazba/stanoviska/659
UNB
Initiative for correction
64386.- breakdown only up to 100g and more than 100g is insufficient.
Big negative impact. On the basis of the reimbursement set up in this way, the PP provided to our patients is not covered by the ZP at that time. For the year 2025 even, the reimbursement for this PP has fallen. In UNB last year, 1770 patients were hospitalized in which the drug albumin was administered. In 649 cases the consumption per patient was more than 100g. The actual cost for these patients was €540,215, the attributable item reimburses only €237,534. The hospital had to cover the difference of €302 681 from its own resources, which contributes to deepening the loss. The analysis does not include the costs incurred by Petržalka Hospital in the period 1-4/2024, as the records are in a different IS. This would make the loss even higher.
The reporting of the administered amount of medicine has been comprehensively revised and set up via markers in the DRG system from 1.1.2026 due to a number of suggestions of a similar nature, which makes the DRG system more flexible in the reporting, as the markers report the exact administered amount of medicine without limits.
Slovenská spoločnosť infektológov
Cefiderocol is included in the List of Medicines with Officially Determined Price from 1.7.2024, it is not currently included in the list of add-on items so that it can be reimbursed separately over and above the price of the inpatient case.
We propose to include cefiderocol in the list of creditable items in the same breakdown as it appears in the list of medical procedures. More detailed reasons for the proposal were provided in feedback No 664.
To the detailed justification, which is part of feedback No.664, we attach the following: o Pharmacoeconomic analysis, which evaluates the cost-effectiveness of the drug in the conditions of the Slovak Republic o Pharmacoeconomic model o Impact of the drug on the budget of the public health insurance The above documents are separately attached.
That request has been reassessed in accordance with Chapter 8 of the Methodology for Updating Attributable Items for SK-DRG 2026, available here: https://www.cksdrg.sk/sk/dokumenty/568/Metodika%20aktualizácie%20pripočítateľných%20položiek%20pre%20SK-DRG%202026.pdf
Given that the criteria were met, the Medical Review Panel proceeded to a vote, which is recorded in the minutes available here: https://www.cksdrg.sk/sk/dokumenty/571/Zápisy%20z%20rokovaní%20medicínsko-analytickej%20pracovnej%20skupiny%20s%20hlasovaniami.pdf
The proposed PP was approved and incorporated into the CMP with a Type A reimbursement in accordance with the above methodology and by vote of the working group with the pricing resulting from the methodology as 90% of the UUC.
Pentahospitals, nemocnica Rožňava
Nemocnica Agel Levoča a.s.
Created at: 27.03.2025
